Prednisolone treatment of lupus nephritis: Effect of high doses on course of disease, renal function, histological lesions, and immunological reactions.
D000293:Adolescent; D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D001706:Biopsy; D001794:Blood Pressure; D001799:Blood Sedimentation; D003165:Complement System Proteins / Q000032:analysis; D003404:Creatinine / Q000097:blood / Q000652:urine; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007501:Iron / Q000097:blood; D007668:Kidney / Q000503:physiopathology; D007677:Kidney Function Tests; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000503:physiopathology; D008214:Lymphocytes; D008297:Male; D009393:Nephritis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000503:physiopathology; D011239:Prednisolone / Q000008:administration & dosage*; D011507:Proteinuria / Q000378:metabolism; D012709:Serum Albumin / Q000032:analysis; D014508:Urea / Q000097:blood; D005719:gamma-Globulins / Q000032:analysis
D000974:Antibodies, Antinuclear; D012709:Serum Albumin; D005719:gamma-Globulins; D014508:Urea; D003165:Complement System Proteins; D011239:Prednisolone; D003404:Creatinine; D007501:Iron